Electromed Inc

ELMD

24.340USD

-0.210-0.86%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

Electromed Inc's Score

Industry at a Glance

Industry Ranking

29 / 208

Overall Ranking

109 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Electromed Inc Highlights

StrengthsRisks

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 33.15% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 64.00M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 64.00M.

Undervalued

The company’s latest PE is 22.80, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 4.36M shares, decreasing 0.04% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 447.28K shares of this stock.

Analyst Rating

Based on 4 analysts

Buy

Current Rating

36.667

Target Price

+49.97%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Electromed Inc is 8.33, ranking 40 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 18.90M, representing a year-over-year increase of 16.25%, while its net profit experienced a year-over-year increase of 40.29%.

Score

Industry at a Glance

Previous score

8.33

Change

0



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.83

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.03

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.40

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.42

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Electromed Inc is 7.29, ranking 96 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 22.80, which is 141.27% below the recent high of 55.02 and 10.87% above the recent low of 20.32.

Score

Industry at a Glance

Previous score

7.29

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 29/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Electromed Inc is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 36.00, with a high of 38.00 and a low of 34.00.

Score

Industry at a Glance

Previous score

8.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Electromed Inc is 9.16, ranking 6 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 25.36 and the support level at 23.38, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.08

Change

0.08

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Electromed Inc is 5.00, ranking 114 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 59.95%, representing a quarter-over-quarter decrease of 0.35%. The largest institutional shareholder is The Vanguard, holding a total of 447.28K shares, representing 5.41% of shares outstanding, with 25.08% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Craney (Stephen H)

600.50K

+2.14%

Winn (George H)

501.15K

-2.70%

The Vanguard Group, Inc.

Star Investors

435.58K

-0.01%

Radoff (Bradley Louis)

350.00K

-43.72%

BlackRock Institutional Trust Company, N.A.

338.12K

+12.46%

Summers Value Partners LLC

270.37K

-19.55%

Two Sigma Investments, LP

249.52K

+0.29%

Acadian Asset Management LLC

195.88K

-17.71%

Geode Capital Management, L.L.C.

189.07K

+21.56%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Electromed Inc is 4.95, ranking 92 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.30. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Electromed Inc

ELMD

7.60 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.13 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Edwards Lifesciences Corp

EW

8.05 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment